GLP-1 Frequently Asked Questions (FAQS)

The Ozempic or Mounjaro jab goes into the skin. This can lead to irritation, minimal bleeding or even redness. It may be best practice to rotate the site for injections to lessen the probability of skin reaction.

• Avoid large amounts of food consumption which could lead to bloating and nausea
• Avoid alcohol which influences blood sugar and could lead to stomach issues in conjunction with Ozempic use.
• Avoid lying down immediately after consuming food because of potential acid reflux issues
• Under-eating or just skipping meals could cause dizziness or fatigue.
• Injecting the GLP-1 into the exact same spot can cause skin irritation,

Were GLP-1 medications prescribed for weight loss historically in the mid-2000s?

Glucagon-like peptide-1 (GLP-1) receptor agonists were initially marketed in the mid-2000s solely for the treatment of type 2 diabetes. The medication was particularly useful with patients who had underlying heart or kidney diseases. GLP-1s worked to improve blood sugar levels and lowered the complications of type 2 diabetes. The drugs helped to lower patient weight, and lowered the the chance of untimely (early) death.

There have been no reported Ozempic stomach paralysis settlements. Without any Wegovy or Ozempic jury verdicts, the range of compensation to be awarded to victims in an ozempic lawsuit is unknown.  Victims pursuing an Ozempic lawsuit most likely will receive receive compensation premised on how severe the injuries are. However, since no Ozempic claims have been resolved yet, it is impossible to determine the exact worth of the claims.

Do side effects continue after stopping ozempic jabs?

A North Carolina man suffering through Gastroparesis purportedly caused by Ozempic use alleges that his side effects endured for months subsequent to discontining the widely prescribed diabetes drug. Michael Hemenway filed an ozempic lawsuit complaint in the U.S. District Court for the Eastern District of Pennsylvania on October 2, 2025. Based on Mr. Hemenway’s side effects, medical providers in the beginning of January 2024 demanded that he cease using Ozempic.  Despite following medical directives and stopping the drug, Mr. Hemenway continued to suffer through the same side effects.  After a medical visit at CCHC Southern Gastroenterology Associates MHC in Morehead City, North Carolina, he was directed to have a gastric emptying study because of his continuing side effects. The gastric emptying study in late February 2024 indicated a 0% level at two hours. This tended to indicate that his suffering from gastroparesis continued despite ceasing Ozempic use in January of 2024.  Even many months later, Mr. hemenway suffers through symptoms of gastroparesis.

What is Ozempic?

Ozempic is another name, (branded) for the drug semaglutide, which is injectable. Semaglutide drops blood sugar levels and maintains insulin. Ozempic is a extremely useful for regulating type 2 diabetes. It has a track record for reducing the risk of cardiovascular disease. The U.S. Food and Drug Administration (FDA), in 2017, greenlighted its use for patients over 18 who are diagnosed with type 2 diabetes.

Ozempic is a GLP-1, which slows stomach emptying, makes appetite smaller and leaves patients with a feeling of stomach fullness. Ozempic is known for leading to weight loss. Once word got out in medical circles about Ozempic leading to weight loss, some doctors commenced prescribing it to patients who do not have diabetes. This is known as  “off label” use.  The FDA has never approved Ozempic for weight loss. However, the FDA has approved, Wegovy for with loss. Wegovy is a  very similar drug also manufactured by Novo Nodisk

Does Ozempic impact the brain?

Ozempic affects a persons relationship with food. Ozempic does not just merely impact how the stomach digests food. Patients prescribed Ozempic have reported a lower amount of “food noise.”  Food noise is when thoughts are continuosly focused on eating food. It could be simplier to engage in weight management if a person does not experience persistent or possibly intrusive thoughts about eating. GLP-1 Drugs could possibly positively influence the manner that a person’s brain ages. A 2025 research study looked at patients with diabetes and determined that patients utilizing GLP-1 drugs could be at a lesser risk of an Alzheimer’s disease diagnosis and assorted types of dementia.

Is Rybelsus different from Ozempic?

Rybelsus is a oral medication tablet taken on a daily basis. Rybelsus contains the same ingredients (semaglutide) as Ozempic which is injectable. Victims can file a Rybelsus lawsuit in the Federal MDL seeking a weight loss drug payout.

Were GLP-1 medications prescribed for weight loss historically in the mid-2000s?

Glucagon-like peptide-1 (GLP-1) receptor agonists were initially marketed in the mid-2000s solely for the treatment of type 2 diabetes. The medication was particularly useful with patients who had underlying heart or kidney diseases. GLP-1s worked to improve blood sugar levels and lowered the complications of type 2 diabetes. The drugs helped to lower patient weight, and lowered the the chance of untimely (early) death.

• • •  Novo Nordisk Inc. is a Delaware corporation with a principal place of business at 800 Scudders Mill Road, Plainsboro, New Jersey, 08536..
    •  Novo Nordisk A/S is a public limited liability company organized under the laws of Denmark with a principal place of business in Bagsværd, Denmark.